Omnicell, Inc. Profile Avatar - Palmy Investing

Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve cli…
Medical - Healthcare Information Services
US, Mountain View [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
43.00 20.00 31.00 39.00 55.00 65.00 33.00 47.00 24.00 103.00 145.00 185.00 231.00 77.00 181.00
Operating Cash (Net)
43.00 20.00 31.00 39.00 55.00 65.00 33.00 47.00 24.00 103.00 145.00 185.00 231.00 77.00 181.00
Accounts Receivable
17.00 -1.00 5.00 -9.00 -3.00 -22.00 -18.00 8.00 -39.00 -6.00 -23.00 12.00 -43.00 -60.00 38.00
Accounts Payable
- - 2.00 -2.00 1.00 -1.00 1.00 -2.00 -4.00 19.00 -9.00 7.00 -6.00 29.00 -7.00 -17.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-3.00 -23.00 -13.00 -168.00 -20.00 -43.00 -45.00 -341.00 -34.00 -54.00 -61.00 -279.00 -412.00 -58.00 -55.00
Capital Expenditure
-3.00 -7.00 -13.00 -20.00 -20.00 -22.00 -20.00 -29.00 -30.00 -54.00 -61.00 -54.00 -58.00 -60.00 -55.00
Purchases of Investments
- - -8.00 -8.00 5.00 - - -1.00 4.00 9.00 -6.00 - - - - 32.00 29.00 - - - -
Sale/Maturity of Investment
1.00 1.00 8.00 8.00 1.00 1.00 -4.00 -9.00 6.00 -1.00 -3.00 -2.00 3.00 -15.00 -10.00
Property, Plant, Equipment (P&PE)
-3.00 -7.00 -13.00 -20.00 -20.00 -22.00 -20.00 -29.00 -30.00 -54.00 -61.00 -54.00 -58.00 -60.00 -55.00
Acquisitions (Net)
- - -5.00 - - -156.00 - - -20.00 -25.00 -312.00 -4.00 - - - - -225.00 -354.00 2.00 - -
Other Investing Activities
-1.00 -3.00 - - -5.00 -1.00 - - - - - - - - 1.00 3.00 -29.00 -32.00 15.00 10.00
Financing Activities
Used Cash (Net)
-9.00 -8.00 -1.00 - - -7.00 - - -31.00 -265.00 -9.00 -13.00 -23.00 -456.00 -47.00 -20.00 -23.00
Debt Repayment
- - - - - - - - - - - - - - -34.00 -102.00 -77.00 -90.00 -200.00 - - - - -2.00
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
69 - - 19 12 20 24 50 - - - - - - 88 158 83 105 30
Other Financing Activities
70.00 1.00 3.00 12.00 28.00 23.00 18.00 300.00 78.00 23.00 76.00 709.00 -3.00 44.00 14.00
Cash Balances
Begin of Period
120.00 169.00 175.00 191.00 62.00 104.00 125.00 82.00 54.00 32.00 67.00 127.00 489.00 355.00 352.00
End of Period
169.00 175.00 191.00 62.00 104.00 125.00 82.00 54.00 32.00 67.00 127.00 489.00 355.00 352.00 500.00
Change
48.00 6.00 16.00 -129.00 42.00 21.00 -43.00 -27.00 -22.00 34.00 60.00 362.00 -134.00 -2.00 148.00
Non-Cash Balances
Depreciation and Amortization
9.00 8.00 7.00 13.00 18.00 20.00 25.00 58.00 51.00 51.00 64.00 71.00 84.00 99.00 95.00
Stock Based Compensation
9.00 9.00 9.00 9.00 11.00 12.00 14.00 19.00 21.00 - - 34.00 44.00 53.00 68.00 55.00
Other
-13.00 -2.00 -3.00 - - 1.00 1.00 -2.00 - - 2.00 2.00 2.00 6.00 22.00 15.00 17.00
Highlighted metrics
Free Cash Flow (FCF)
39.00 13.00 18.00 18.00 34.00 42.00 13.00 18.00 -5.00 49.00 83.00 131.00 173.00 17.00 126.00
Cash Conversion Cycle (CCC)
70.00 58.00 78.00 86.00 87.00 89.00 118.00 119.00 140.00 146.00 137.00 120.00 108.00 127.00 120.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of OMCL's Analysis
CIK: 926326 CUSIP: 68213N109 ISIN: US68213N1090 LEI: - UEI: -
Secondary Listings
OMCL has no secondary listings inside our databases.